AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7552187 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 30
Study 7552187 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 30
Study 1682327 — intervention group
Group type: EXPERIMENTAL
Intervention: Benadryl (Parke‐Davis, Morris Plains N.J.)
Number of subjects: 100
Study 1682327 — intervention group
Group type: EXPERIMENTAL
Intervention: Atarax (Roerig Div. of Pfizer Inc., New York, N.Y.)
Number of subjects: 100
Study 1682327 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyhist Forte (Mikart Inc., Atlanta, Ga.)
Number of subjects: 100
Study 1682327 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 100
Study 7028798 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 30
Study 7028798 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 30
Study 7028798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30849057 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Program for Early Psychosis (ePEP)
Number of subjects: 0
Study 28818417 — intervention group
Group type: EXPERIMENTAL
Intervention: Five face‐to‐face counseling sessions by an exercise specialist
Number of subjects: 203
Study 28818417 — intervention group
Group type: EXPERIMENTAL
Intervention: One face‐to‐face counseling session followed by four telephone calls by an exercise specialist
Number of subjects: 203
Study 28818417 — intervention group
Group type: COMPARATOR
Intervention: Generic mailed physical activity brochure (usual care)
Number of subjects: 203
Study 26471584 — intervention group
Group type: EXPERIMENTAL
Intervention: Malted wheat (MLT)
Number of subjects: 10
Study 26471584 — intervention group
Group type: COMPARATOR
Intervention: Whole-grain wheat (CON)
Number of subjects: 10
Study 25153776 — intervention group
Group type: EXPERIMENTAL
Intervention: transcranial oscillating direct current stimulation (toDCS) at 0.75 Hz
Number of subjects: 12
Study 25153776 — intervention group
Group type: COMPARATOR
Intervention: sham condition
Number of subjects: 12
Study 22568921 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg IV or orally every 12 h
Number of subjects: 477
Study 22568921 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 15 mg/kg or 1 g IV every 12 h
Number of subjects: 477
Study 22568921 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 477
Study 22568921 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 477
Study 19293413 — intervention group
Group type: EXPERIMENTAL
Intervention: Pactimibe 100 mg/d
Number of subjects: 892
Study 19293413 — intervention group
Group type: EXPERIMENTAL
Intervention: Pactimibe
Number of subjects: 892
Study 19293413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 892
Study 17260529 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboptimal vitamin B6 status
Number of subjects: 0
Study 17260529 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated homocysteine concentrations
Number of subjects: 0
Study 17260529 — intervention group
Group type: EXPERIMENTAL
Intervention: Other mechanisms independent of homocysteine
Number of subjects: 0
Study 16365466 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 101
Study 16365466 — intervention group
Group type: COMPARATOR
Intervention: Self-care book
Number of subjects: 101
Study 16365466 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapeutic exercise
Number of subjects: 101
Study 12507242 — intervention group
Group type: EXPERIMENTAL
Intervention: 3i threaded implants (self-tapping, ICE, Osseotite)
Number of subjects: 528
Study 9842837 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg
Number of subjects: 100
Study 9842837 — intervention group
Group type: COMPARATOR
Intervention: Domperidone 20 mg
Number of subjects: 100
Study 8445432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate (10 mg) twice weekly
Number of subjects: 59
Study 8445432 — intervention group
Group type: COMPARATOR
Intervention: Thiotepa (10 mg) twice weekly
Number of subjects: 59
Study 3731893 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursed lips breathing (PLB)
Number of subjects: 12
Study 3731893 — intervention group
Group type: COMPARATOR
Intervention: General relaxation (Rlx)
Number of subjects: 12
Study 30346225 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-dense enteral nutrition (1.5 kcal/ml)
Number of subjects: 3957
Study 30346225 — intervention group
Group type: COMPARATOR
Intervention: Routine enteral nutrition (1.0 kcal/ml)
Number of subjects: 3957
Study 27060053 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphodiesterase type 5 inhibitor
Number of subjects: 0
Study 24799001 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal depressive symptoms
Number of subjects: 225
Study 24799001 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher involvement expectancies
Number of subjects: 225
Study 24799001 — intervention group
Group type: EXPERIMENTAL
Intervention: Poorer youth adherence
Number of subjects: 225
Study 23189136 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (15 mins/1 mA)
Number of subjects: 15
Study 23189136 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (15 mins/1 mA)
Number of subjects: 15
Study 23189136 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (15 mins/1 mA)
Number of subjects: 15
Study 21198247 — intervention group
Group type: EXPERIMENTAL
Intervention: Client feedback condition
Number of subjects: 0
Study 21198247 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 0
Study 16701078 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for 3 months
Number of subjects: 117
Study 16701078 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 117
Study 15766833 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 3817
Study 15766833 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 3817
Study 11888460 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymeric sealant (CoSeal)
Number of subjects: 148
Study 11888460 — intervention group
Group type: COMPARATOR
Intervention: Gelfoam/thrombin
Number of subjects: 148
Study 10223535 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic technique including a capsular plication
Number of subjects: 41
Study 10223535 — intervention group
Group type: COMPARATOR
Intervention: Open procedure with Mitec anchors
Number of subjects: 41
Study 7542973 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraline fiber
Number of subjects: 93
Study 7542973 — intervention group
Group type: EXPERIMENTAL
Intervention: Urolase fiber
Number of subjects: 93
Study 2039173 — intervention group
Group type: EXPERIMENTAL
Intervention: BSS Plus
Number of subjects: 0
Study 2039173 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's with dextrose and bicarbonate
Number of subjects: 0
Study 6939009 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 27
Study 6939009 — intervention group
Group type: EXPERIMENTAL
Intervention: l-amphetamine
Number of subjects: 27
Study 6939009 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study 31642718 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic endoscopic closure after colorectal ESD
Number of subjects: 220
Study 31642718 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic endoscopic closure after colorectal ESD
Number of subjects: 220
Study 28775307 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferential attachment (PA) model
Number of subjects: 0
Study 28775307 — intervention group
Group type: EXPERIMENTAL
Intervention: Shocks of differing length and severity (attacks and errors)
Number of subjects: 0
Study 28775307 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term shocks
Number of subjects: 0
Study 28775307 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated attacks
Number of subjects: 0
Study 28775307 — intervention group
Group type: EXPERIMENTAL
Intervention: Attacks vs. errors
Number of subjects: 0
Study 25880068 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide sustained release 1.5 mg ± perindopril 2 to 4 mg
Number of subjects: 0
Study 25880068 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study 24091772 — intervention group
Group type: EXPERIMENTAL
Intervention: Fittslog condition
Number of subjects: 0
Study 24091772 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinelog condition
Number of subjects: 0
Study 24091772 — intervention group
Group type: COMPARATOR
Intervention: Fitts condition
Number of subjects: 0
Study 21927686 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at the rate of 0.17 µg/kg/min
Number of subjects: 80
Study 21927686 — intervention group
Group type: COMPARATOR
Intervention: N(2)O (70%)
Number of subjects: 80
Study 21927686 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion
Number of subjects: 80
Study 21927686 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 80
Study 19728002 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular block
Number of subjects: 103
Study 19728002 — intervention group
Group type: COMPARATOR
Intervention: Dual motor endpoint nerve stimulation infraclavicular block
Number of subjects: 103
Study 17767023 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study 15531676 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate (FS)
Number of subjects: 323
Study 15531676 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate and zinc sulfate (FSZn)
Number of subjects: 323
Study 15531676 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate, zinc sulfate, and vitamin A (FSZnA)
Number of subjects: 323
Study 11433856 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal appliances
Number of subjects: 0
Study 11433856 — intervention group
Group type: COMPARATOR
Intervention: Nonoccluding appliances
Number of subjects: 0
Study 11433856 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study 9771209 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI of the wrist
Number of subjects: 42
Study 9771209 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA‐DRB1*04 or *01 (shared epitope +ve)
Number of subjects: 42
Study 7793548 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural infusion of bupivacaine 0.125% with diamorphine 0.0025%
Number of subjects: 63
Study 7793548 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural infusion of bupivacaine 0.062% with diamorphine 0.0025%
Number of subjects: 63
Study 7793548 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural infusion of bupivacaine 0.031% with diamorphine 0.0025%
Number of subjects: 63
Study 7793548 — intervention group
Group type: EXPERIMENTAL
Intervention: All bupivacaine infusions
Number of subjects: 63
Study 2569488 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (0.6 g/day)
Number of subjects: 40
Study 2569488 — intervention group
Group type: COMPARATOR
Intervention: Sulfasalazine (2 g/day)
Number of subjects: 40
Study 798195 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil
Number of subjects: 80
Study 798195 — intervention group
Group type: COMPARATOR
Intervention: clofibrate
Number of subjects: 80
Study 31443919 — intervention group
Group type: EXPERIMENTAL
Intervention: modified Valsalva maneuver (mVM)
Number of subjects: 98
Study 31443919 — intervention group
Group type: EXPERIMENTAL
Intervention: standard Valsalva maneuver (sVM)
Number of subjects: 98
Study 31443919 — intervention group
Group type: EXPERIMENTAL
Intervention: carotid sinus massage (CSM)
Number of subjects: 98
Study 27914730 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dimensional monitor
Number of subjects: 20
Study 27914730 — intervention group
Group type: COMPARATOR
Intervention: 2-dimensional monitor
Number of subjects: 20
Study 25629571 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Entonox use
Number of subjects: 100
Study 25629571 — intervention group
Group type: COMPARATOR
Intervention: As-required Entonox use
Number of subjects: 100
Study 25629571 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with high anxiety
Number of subjects: 100
Study 23614401 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentiated ZPT formula
Number of subjects: 620
Study 23614401 — intervention group
Group type: COMPARATOR
Intervention: Dual Active shampoo
Number of subjects: 620
Study 21862679 — intervention group
Group type: EXPERIMENTAL
Intervention: Aphasia group
Number of subjects: 7
Study 21862679 — intervention group
Group type: COMPARATOR
Intervention: Age-matched control group (N=9)
Number of subjects: 7
Study 21862679 — intervention group
Group type: COMPARATOR
Intervention: Younger control group (N=10)
Number of subjects: 7
Study 19550340 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose 1 microg/kg for 10 min followed by infusion of 0.2-0.7 microg/kg/h)
Number of subjects: 61
Study 19550340 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (bolus dose 0.04 mg/kg followed by infusion of 0.04-0.08 mg/kg/h)
Number of subjects: 61
Study 16537075 — intervention group
Group type: EXPERIMENTAL
Intervention: Identifiable icons
Number of subjects: 0
Study 16537075 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium icons
Number of subjects: 0
Study 16537075 — intervention group
Group type: COMPARATOR
Intervention: Vague icons
Number of subjects: 0
Study 15491379 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch-up growth group (22 children)
Number of subjects: 30
Study 15491379 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with PEM who did not show catch-up growth (8 children)
Number of subjects: 30
Study 15491379 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified how many)
Number of subjects: 30
Study 11686450 — intervention group
Group type: EXPERIMENTAL
Intervention: 350‐centistroke polydimethicone (n = 16)
Number of subjects: 31
Study 11686450 — intervention group
Group type: COMPARATOR
Intervention: Sterile saline (n = 15)
Number of subjects: 31
Study 9692106 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation after combined beta- and atropinic blockade in mild asthmatics
Number of subjects: 24
Study 9692106 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation in nocturnal asthmatics after atropinic blockade alone
Number of subjects: 24
Study 9692106 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation in normal subjects after atropine plus propranolol
Number of subjects: 24
Study 7869682 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined superior oblique tendon tuck of 5 or 6 mm with transposition of the new insertion to the posterior margin of the original insertion and recession of the inferior oblique muscle of 5 or 6 mm with anterior displacement of 4‐6 mm (Group A)
Number of subjects: 38
Study 7869682 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional superior oblique tendon tuck of 5 or 6 mm combined with recession of the inferior oblique muscle (Group B)
Number of subjects: 38
Study 7869682 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional superior oblique tendon tuck of 6 mm combined with posterior tenotomy of the inferior oblique muscle (Group C)
Number of subjects: 38
Study 3653590 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg tid
Number of subjects: 10
Study 3653590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30138085 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MTX (COG-augmented BFM regimen)
Number of subjects: 1895
Study 30138085 — intervention group
Group type: COMPARATOR
Intervention: HDMTX (Berlin-Frankfurt-Muenster high-dose intravenous MTX regimen)
Number of subjects: 1895
Study 28456330 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 56
Study 28456330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 26263075 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg (group R)
Number of subjects: 117
Study 26263075 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 4 mg (group O4)
Number of subjects: 117
Study 26263075 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 8 mg (group O8)
Number of subjects: 117
Study 26263075 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (R, O4, O8)
Number of subjects: 117
Study 24024826 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care intervention including self-help material, chat forum, FAQ section, and cognitive behavioral therapy (CBT) administered by a personal therapist if symptoms persist.
Number of subjects: 0
Study 24024826 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study 21908956 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy (performed in 213 patients)
Number of subjects: 425
Study 21908956 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pericardial incision performed in 212 patients)
Number of subjects: 425
Study 21908956 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy
Number of subjects: 425
Study 19159941 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-tonsillectomy injection of bupivacaine
Number of subjects: 180
Study 19159941 — intervention group
Group type: COMPARATOR
Intervention: Pre-incisional infiltration technique
Number of subjects: 180
Study 19159941 — intervention group
Group type: COMPARATOR
Intervention: Post-tonsillectomy packing with 0.5% bupivacaine-soaked gauze swab
Number of subjects: 180
Study 17565235 — intervention group
Group type: EXPERIMENTAL
Intervention: Melagatran/Ximelagatran
Number of subjects: 0
Study 17565235 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0
Study 14739050 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced fat (RF) diet
Number of subjects: 136
Study 14739050 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (control, CD)
Number of subjects: 136
Study 10669363 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent live attenuated influenza vaccine (LAIV)
Number of subjects: 111
Study 10669363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 9107443 — intervention group
Group type: COMPARATOR
Intervention: Verapamil SR monotherapy 120 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: COMPARATOR
Intervention: Verapamil SR monotherapy 180 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: COMPARATOR
Intervention: Verapamil SR monotherapy 240 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: COMPARATOR
Intervention: Trandolapril monotherapy 0.5 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril monotherapy 2 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril monotherapy 8 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy 0.5/120 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy 0.5/180 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy 2/180 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy 2/240 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy 8/240 mg
Number of subjects: 746
Study 9107443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 746
Study 1315560 — intervention group
Group type: EXPERIMENTAL
Intervention: Renin inhibitor CGP 38560A (125 micrograms kg‐1)
Number of subjects: 6
Study 1315560 — intervention group
Group type: EXPERIMENTAL
Intervention: Renin inhibitor CGP 38560A (250 micrograms kg‐1)
Number of subjects: 6
Study 1315560 — intervention group
Group type: COMPARATOR
Intervention: 5% glucose (control)
Number of subjects: 6
Study 1315560 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor lisinopril (20 mg)
Number of subjects: 6
Study 3964713 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 117
Study 3964713 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 117
Study 31925600 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First (HF)
Number of subjects: 0
Study 31925600 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 30957391 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel-aspirin dual treatment
Number of subjects: 0
Study 30957391 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 29871668 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent, rapid, on-site testing and treatment (TnT)
Number of subjects: 480
Study 29871668 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TnT)
Number of subjects: 480
Study 26740254 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose black raspberry (2500 mg/d)
Number of subjects: 45
Study 26740254 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose black raspberry (1500 mg/d)
Number of subjects: 45
Study 26740254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 24699059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tissue‐type plasminogen activator followed by endovascular treatment
Number of subjects: 656
Study 24699059 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tissue‐type plasminogen activator alone
Number of subjects: 656
Study 22694864 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Touch (HT)
Number of subjects: 20
Study 22694864 — intervention group
Group type: COMPARATOR
Intervention: Presence care (Control)
Number of subjects: 20
Study 19086054 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative-bonding intervention (CBI)
Number of subjects: 100
Study 19086054 — intervention group
Group type: COMPARATOR
Intervention: Friendly visit (FV) control group
Number of subjects: 100
Study 17185020 — intervention group
Group type: EXPERIMENTAL
Intervention: Idursulfase at 0.15 mg/kg infused every other week
Number of subjects: 12